MetLife (MET) Q2 2026: Adjusted Earnings Up 15%, Adjusted EPS Up 20%, GAAP Up 1%
MetLife's underwriting and investment engines both improved in the second quarter, but almost none of that reached the GAAP bottom line. Adjusted earnings — the company's own segment-performance measure — rose 15.1% to $1,604 million, while net income attributable to MetLife crept up just 1.0% to $736 million, leaving an $868 million gap between the two. The largest component of that wedge is $1,200 million of combined net investment losses ($428 million) and net derivative losses ($772 million), the accounting shadow of hedging a liability book that is not marked to market alongside it; the remaining items — MRB remeasurement gains of $270 million, investment hedge adjustments of −$170 million, real-estate and REJV depreciation of −$54 million, other items of +$95 million, a tax benefit of $234 million, and a noncontrolling-interest deduction of $43 million — net to +$332 million, and $1,200 million less $332 million accounts for the full $868 million divergence. For an insurer, the question is not which number is "correct" but which one predicts next year's cash — and on that test the operating detail matters more than the headline.
The market took the same view. On the company's own measure, adjusted EPS rose 20% to $2.43, beating consensus of roughly $2.36, and adjusted return on equity reached 17.0% — the top of MetLife's 15–17% target range. Total revenue of $19.15 billion, by contrast, fell short of the roughly $19.68 billion analysts expected. Investors sided with the earnings line: the stock rose about 3.7% to $99.78, near its 52-week high. (Adjusted EPS, adjusted ROE, variable investment income and buyback figures cited in this article come from MetLife's Q2 2026 earnings release and August 2026 earnings call; all balance-sheet, income-statement and cash-flow figures are from the Q2 2026 Form 10-Q.)
1. Balance Sheet: Deposits Grow, Equity Shrinks
1-1. Principal Asset Items
| Item | Dec 31, 2025 ($M) | Jun 30, 2026 ($M) | Change % |
|---|---|---|---|
| Fixed maturity securities AFS | 315,931 | 322,183 | +2.0% |
| Mortgage loans | 84,593 | 82,856 | −2.1% |
| Short-term investments | 3,601 | 8,016 | +122.6% |
| Total investments | 472,178 | 482,563 | +2.2% |
| Cash and cash equivalents | 22,032 | 19,301 | −12.4% |
| Premiums, reinsurance and other receivables | 49,059 | 50,635 | +3.2% |
| DAC and VOBA | 21,107 | 21,571 | +2.2% |
| Goodwill | 9,613 | 9,536 | −0.8% |
| Separate account assets | 151,933 | 156,850 | +3.2% |
| Total assets | 745,166 | 759,372 | +1.9% |
The most informative line is the one investors rarely read: amortized cost on the AFS portfolio is $347,781 million against $322,183 million of fair value, an unrealized loss position of $25,598 million that widened from $21,270 million at year-end — $4,328 million of additional mark-to-market pain in six months. Because these are available-for-sale securities held against long-dated liabilities, the loss sits in other comprehensive income rather than earnings, and it reverses as bonds pull to par. But it is the direct reason book value is falling while earnings rise.
